The integration of machine learning into traditional Chinese medicine DOI Creative Commons

Yanfeng Hong,

Sisi Zhu,

Yuhong Liu

et al.

Journal of Pharmaceutical Analysis, Journal Year: 2024, Volume and Issue: unknown, P. 101157 - 101157

Published: Dec. 1, 2024

Language: Английский

Uncovering the Scientific Landscape: A Bibliometric and Visualized Analysis of Artificial Intelligence in Traditional Chinese Medicine DOI Creative Commons
Siyang Cao, Yihao Wei, Yaohang Yue

et al.

Heliyon, Journal Year: 2024, Volume and Issue: unknown, P. e37439 - e37439

Published: Sept. 1, 2024

Language: Английский

Citations

5
AI Empowering Traditional Chinese Medicine? DOI Creative Commons

Zhilin Song,

Guanxing Chen, Calvin Yu‐Chian Chen

et al.

Chemical Science, Journal Year: 2024, Volume and Issue: unknown

Published: Jan. 1, 2024

AI-powered analysis of TCM chemical data enhances component identification, drug discovery, personalized treatment, and pharmacological action elucidation, driving the modernization sustainable development TCM.

Language: Английский

Citations

5
Therapeutic potential and pharmacological mechanisms of Traditional Chinese Medicine in gout treatment DOI

Jing-wen Guo,

Guo‐Qiang Lin,

Xinyi Tang

et al.

Acta Pharmacologica Sinica, Journal Year: 2025, Volume and Issue: unknown

Published: Jan. 17, 2025

Language: Английский

Citations

0
Mpm-Net: Multi-Task Interactive Network with Progressive Multi-Granularity Learning for Image Recognition of Chinese Herbal Medicine DOI
Kaiwen Yang, Guanqun Ding, Leyuan Sun

et al.

Published: Jan. 1, 2025

Language: Английский

Citations

0
Examining how fiscal policies influence innovation in TCM enterprises: the role of R&D investment and executives with pharmaceutical backgrounds DOI Creative Commons

Dan Guo,

Liwen Qi,

Xiaoting Song

et al.

Frontiers in Public Health, Journal Year: 2025, Volume and Issue: 13

Published: Feb. 26, 2025

Innovation is crucial to realize the modernization and industrialization of traditional Chinese medicine (TCM), so its incentive methods influence mechanisms are worth exploring. Based on externality theory imprinting theory, this paper demonstrates significance external support internal resources in innovation TCM enterprises. This study adopts a sample listed enterprises China during 2007-2023 examine impacts differences between subsidies tax incentives enterprise innovation. deconstructed into five dimensions, including quantity (InNum), quality (InQua), substantive (SubIn), strategic (StrIn), inheritance (InhIn). It found that effect other dimensions firms generally stronger than incentives, except for Heterogeneity analysis indicates promoting more significant southern production region. Moreover, R&D investment mediates relationship Furthermore, executives with pharmaceutical backgrounds (EPB) strengthen impact various enterprises, while EPB only strengthens The findings provide new insights government promote

Language: Английский

Citations

0
Traditional Chinese medicine as a promising choice for future control of PEDV DOI Creative Commons

Cheng-ye Ji,

Shuxuan Li,

Christine Hu

et al.

Virus Research, Journal Year: 2025, Volume and Issue: unknown, P. 199572 - 199572

Published: April 1, 2025

Porcine epidemic diarrhea virus (PEDV) is the major agent of recent outbreaks in piglets, which has caused huge economic losses to global swine industry. Since traditional vaccine strategies cannot provide complete protection for development safe, effective, and economical antiviral drugs urgently needed. For many years, Chinese medicines (TCMs) have been broadly applied viral infectious diseases, exhibiting advantages such as abundant resources, lower toxicity, minimal drug resistance. Many herbal monomers, single extracts derived from these drugs, recipes exhibit significant anti-PEDV effects vitro and/or vivo by targeting multiple sites perspectives, including inhibition life cycle, anti-inflammation effects, enhancement host immune response, modulation reactive oxygen species, apoptosis. However, date, no review published on TCM. Therefore, this summarizes current control PEDV systematically analyses research progress TCMs against PEDV. Furthermore, future directions integration nanotechnology artificial intelligence with are also discussed. This will a valuable reference studies research.

Language: Английский

Citations

0
Development of digital therapeutics in Hwa-byung treatment: exploring innovation potential in Korean medicine through practitioner survey DOI Creative Commons
Chan‐Young Kwon

Frontiers in Medicine, Journal Year: 2025, Volume and Issue: 11

Published: Jan. 15, 2025

Hwa-byung (HB) is a culture-bound anger syndrome prevalent in Korea. While clinical practice guidelines emphasize mind-body modalities (MBMs) and psychotherapies for HB treatment, their implementation Korean medicine (KM) remains unexplored. Digital therapeutics (DTx) offers potential solutions treatment delivery barriers. This study investigated current practices among KM doctors perceptions on DTx implementation. A nationwide web-based survey of licensed KMDs (N = 864) was conducted South Korea (August-September 2024). The assessed practices, utilization MBMs psychotherapies, attitudes toward DTx. Data were analyzed using descriptive statistics. Most utilized conventional treatments (acupuncture 95.4%, herbal 94.0%), while (26.2%) (21.3%) underutilized despite recognized importance. Primary barriers included time constraints (65.8%) insufficient knowledge (62.9%). Treatment typically required 15.6 ± 60.7 weeks with 21.6 37.4 sessions. limited (mean score 2.3 0.9/5), most (70.6%) expressed interest development, 65.4% willing to implement it practice. estimated appropriate cost 24,441.5 13,566.0 KRW per session. reveals significant gap between particularly implementing psychotherapies. positive attitude suggests its as practical solution bridge this by providing accessible, standardized evidence-based psychological interventions within existing workflows. Future development should focus addressing identified maintaining alignment principles.

Language: Английский

Citations

0
Chinese and western medicine treatment of myocardial fibrosis drugs DOI Creative Commons
Yuxi Zhu, Fangmei Zhang, Zhongcheng Li

et al.

Frontiers in Cardiovascular Medicine, Journal Year: 2025, Volume and Issue: 11

Published: Jan. 15, 2025

Myocardial fibrosis (MF) is a common pathological manifestation of many cardiovascular diseases, such as myocardial infarction, ischemia, and sudden cardiac death. It characterized by excessive proliferation activation fibroblasts, transformation into myofibroblasts, and, eventually, deposition the extracellular matrix, resulting in heart damage. Currently, modern drugs angiotensin-converting enzyme inhibitors, diuretics, β-blockers can improve clinical treatment, but their therapeutic effect on this disease limited, with obvious side effects high cost. Traditional Chinese medicine (TCM) has advantages multiple targets, low cost, few effects. medicines, Salvia miltiorrhiza, Astragalus, Angelica extracts, patent Qiliqiangxin capsules, Shenqi Yiqi dropping pills, Tongxinluo fibrosis. In review, current Western methods for treating are discussed. The signaling pathways targets involved treatment This review aimed to provide valuable insights ideas both basic research

Language: Английский

Citations

0
A Novel Paradigm on Data and Knowledge-Driven Drug Formulation Development: Opportunities and Challenges of Machine Learning DOI
Xinrui Wang,

Zhenda Liu,

Lin Xiao

et al.

Journal of Industrial Information Integration, Journal Year: 2025, Volume and Issue: unknown, P. 100796 - 100796

Published: Feb. 1, 2025

Language: Английский

Citations

0
A Review of Recent Artificial Intelligence for Traditional Medicine DOI Creative Commons
Chengbin Hou, Yifan Gao, Xinyu Lin

et al.

Journal of Traditional and Complementary Medicine, Journal Year: 2025, Volume and Issue: unknown

Published: Feb. 1, 2025

Language: Английский

Citations

0